You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RARE Sale Disclosure
Huizenga Theodore Alan · SEC Form 4 · Filed Sep 15, 2026
Sale
Calculated transaction value
$17.41K
Huizenga Theodore Alan SVP, Chief Accounting Officer
RARE
Transaction date
Sep 15, 2026
Public filing date
Sep 15, 2026
Filing lag
Filed same day
RARE daily price context
Close on/before transaction
$13.07
Sep 15, 2026
First close after public filing
$12.88
Sep 16, 2026
30-day return after filing
+17.78%
Through Oct 15, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,283 shares @ $13.57
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-392233
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$17.41K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. RARE Current | Sale | Sep 15, 2026 | $17.41K |